Scholar Rock Holding (SRRK) Equity Ratio (2017 - 2026)
Scholar Rock Holding (SRRK) recorded quarterly Equity Ratio of 0.52 in Q1 2026, down 15.08% quarter-over-quarter from 0.61 in Q4 2025, and down 32.71% on a YoY basis from 0.77 in Q1 2025.
Scholar Rock Holding (SRRK) Equity Ratio (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Equity Ratio history runs 10 years deep, the most recent figure standing at 0.52 for Q1 2026.
- In Q1 2026, Equity Ratio fell 32.71% year-over-year to 0.52; the TTM figure through Mar 2026 stood at 0.52 (down 32.71% YoY), while the FY2025 annual figure was 0.61, down 21.77% from the prior year.
- Equity Ratio was 0.52 for Q1 2026 at Scholar Rock Holding, down from 0.61 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.78 in Q2 2022 to a low of 0.44 in Q3 2024.
- Historically, Equity Ratio has averaged 0.67 across 5 years, with a median of 0.69 in 2025.
- The sharpest annual moves came in 2024 and 2025: Equity Ratio plunged 33.9% in 2024, then surged 34.6% in 2025.
- A 5-year view of Equity Ratio shows it stood at 0.73 in 2022, then retreated by 0.34% to 0.72 in 2023, then gained by 7.2% to 0.78 in 2024, then fell by 21.77% to 0.61 in 2025, then retreated by 15.08% to 0.52 in 2026.
- The last three Equity Ratio figures came in at 0.52 (Q1 2026), 0.61 (Q4 2025), and 0.6 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 191.07 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.98 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 0.04 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.42 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.73 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 0.79 |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - | 0.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.52 |
| Dec 31, 2025 | 0.61 |
| Sep 30, 2025 | 0.60 |
| Jun 30, 2025 | 0.69 |
| Mar 31, 2025 | 0.77 |
| Dec 31, 2024 | 0.78 |
| Sep 30, 2024 | 0.44 |
| Jun 30, 2024 | 0.59 |
| Mar 31, 2024 | 0.68 |
| Dec 31, 2023 | 0.72 |
| Sep 30, 2023 | 0.67 |
| Jun 30, 2023 | 0.71 |
| Mar 31, 2023 | 0.73 |
| Dec 31, 2022 | 0.73 |
| Sep 30, 2022 | 0.75 |
| Jun 30, 2022 | 0.78 |
| Mar 31, 2022 | 0.64 |
| Dec 31, 2021 | 0.57 |
| Sep 30, 2021 | 0.63 |
| Jun 30, 2021 | 0.65 |